2008
DOI: 10.1016/s2173-5085(08)70036-4
|View full text |Cite
|
Sign up to set email alerts
|

The Participation of the Pharmacist in the Design and Follow-up of the Drug Treatment Plan for Patients With a Cardiovascular Condition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…The agreement between the reviewers with respect to article selection was “substantial” [ κ = 0.69 (95%CI, 0.65–0.73)]. Ultimately, a total of 147 articles were included in the review (Figure ), which included 120 original articles and 27 review articles. Figure shows the distribution of the included articles sorted by type and year of publication.…”
Section: Resultsmentioning
confidence: 99%
“…The agreement between the reviewers with respect to article selection was “substantial” [ κ = 0.69 (95%CI, 0.65–0.73)]. Ultimately, a total of 147 articles were included in the review (Figure ), which included 120 original articles and 27 review articles. Figure shows the distribution of the included articles sorted by type and year of publication.…”
Section: Resultsmentioning
confidence: 99%
“…Hospital admission, discharge, and follow-up programs have shown that when pharmacists are included in HIE and transitions of care efforts, enhanced problem detection and resolution occurs. 10 19 However, similar efforts in community pharmacies are limited as community pharmacies’ inclusion in HIE is rare. Although the US Office of the National Coordinator envisions pharmacies’ involvement in HIE, current policy discourages community pharmacists’ engagement in HIE for 2 reasons.…”
Section: Introductionmentioning
confidence: 99%